cuts Poviztra price by 55% for patients. Emcure Pharmaceuticals reduced the starting dose price of its weight management drug Poviztra by 55%, making it ₹3,999 per month and ₹999 weekly. The revised prices apply to all doses with an average 47% reduction, making the therapy more affordable for a wider patient base, effective from April 3, 2026. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.